@FierceMedDev: Foundation Medicine eyes $92M in IPO. ICYMI Friday | Follow @FierceMedDev
@DamianFierce: Columbia Labs is buying into the CRO biz for $25M, grabbing Molecular Profiles. More from FierceCRO | Follow @DamianFierce
@MarkHFierce: Touch may help prevent hacking of insulin pumps and other wireless, implanted devices. Article via MIT Technology Review. | Follow @MarkHFierce
@MichaelGFierce: Delcath's chemo delivery device suffers FDA rejection. ICYMI from FierceDrugDelivery | Follow @MichaelGFierce
> Arthrex wants the U.S. Supreme Court to hear an appeal of its $85 million patent infringement loss to Smith & Nephew ($SNN). Story
> Corindus Vascular Robotics has started a study testing the safety and effectiveness of robotic angioplasty procedures. Item
> Stent developer InspireMD brought on a new head of global marketing and strategy. Item
> CytoSorbents will link with Biocon to bring its blood purification device to India. Story
Biotech News
@FierceBiotech: Veeva, provider of sales software to Merck, seeks up to $150M in IPO. Story from FierceBiotech IT | Follow @FierceBiotech
@JohnCFierce: ICYMI: ViroPharma shares soar on report of possible buyout offer. Article | Follow @JohnCFierce
@EmilyMFierce: Cheaper sequencing points cancer drug researchers to 'super responders.' More | Follow @EmilyMFierce
> Biosimilars developer Celltrion defends against allegations of insider trading. Report
> NovaBay shares jump on positive PhII catheter solution study. Item
> Chiesi values Cornerstone Therapeutics at $255M in buyout deal. Story
> FDA lifts hold on Pluristem's stem cell trial after tweaking protocol. News
Pharma News
@FiercePharma: GSK's happy: Arzerra won FDA breakthrough status; now, priority review for melanoma combo Tafinlar + Mekinist. Article | Follow @FiercePharma
@EricPFierce: GSK, Genmab get FDA 'breakthrough' designation for Arzerra in first-line use. ICYMI Friday | Follow @EricPFierce
@CarlyHFierce: Check out the new report by @EricPFierce: Top 10 rheumatoid arthritis drugs 2013. Feature | Follow @CarlyHFierce
> Roche lands Lufthansa CEO to take over chairman's job. News
> New Ranbaxy import ban provides Novartis with unexpected benefit. Story
> Viehbacher: Sanofi's options include buying back stake from L'Oreal, upping stake in Regeneron. Article
CRO News
> Harlan ups its European presence. Item
> Theorem teams with Charles River on preclinical work. Report
> Indian CRO TCG teams with Debiopharm for antibiotics. More
> Bayer taps DKSH with eye on Singapore. Story
> Italy's CROS NT reaches into U.S. with Stat-Tech buyout. Article
Biotech IT News
> TranSMART releases new version of research software from Johnson & Johnson. Item
> Qlucore corrals EU funding for hepatitis C software. Report
> AstraZeneca supports iPhone app for helping patients with heart disease. Article
> MIT center grabs $25M grant to build human-like computers. More
> Treato releases latest software: not another social media-listening app for pharma? Story